← Back to Patent Explorer
US4673686A Expired / Lapsed US ⏱️ 0.0 years remaining

New substituted heterocyclic benzamides, methods of preparing them and their application as behavior modifiers

Assignee: Societe dEtudes Scientifiques et Industrielles de lIle de France SA
•
Filing: 1985-08-26
•
Granted: 1987-06-16
•
Expires: 2005-08-26
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract There are provided new substituted heterocyclic benzamides and derivatives thereof which provide modifications on the central nervous system.

Inventors

  • 👤 Michel Thominet
  • 👤 Jacques Acher
  • 👤 Jean-Claude Monier

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-07 21:44
CPC Classifications
C; C07; C07D; C07D207/00; C07D207/02; C07D207/04; C07D207/10; C07D207/14; A; A61; A61P; A61P1/00; A61P1/08; A61P25/00; A61P25/18; C07C; C07C309/00; C07C317/00; C07C323/00; C07C65/00; C07C65/21; C07C65/28; C07D207/08; C07D207/09; C07D403/00; C07D403/02

Claims Analysis

Total Claims: 11
Claim 1
Independent Claim 88 words
Substituted heterocyclic benzamides, their salts of addition with pharmacologically acceptable acids, their quaternary ammonium salts, their N-oxides and their optically active isomers, of formula (I): ##STR7## wherein: A is a single bond R 4 is a norbornyl or adamantyl group R 5 is a C 1-3 alkyl group R 1 is a sulfamoyl group or a, C 1-3 alkylsulfonyl group R 2 is a hydrogen or halogen atom, an amino group or is joined with R 1 to form an azimido group R 3 is a hydrogen atom.
Claim 2
Dependent Claim 88 words
Substituted heterocyclic benzamides, their salts of addition with pharmacologically acceptable acids, their quaternary ammonium salts, their N-oxides and their optically active isomers, of formula (I): ##STR7## wherein: A is a single bond R 4 is a norbornyl or adamantyl group R 5 is a C 1-3 alkyl group R 1 is a sulfamoyl group or a, C 1-3 alkylsulfonyl group R 2 is a hydrogen or halogen atom, an amino group or is joined with R 1 to form an azimido group R 3 is a hydrogen atom.
Claim 3
Dependent Claim 65 words
The substituted heterocyclic benzamides of claim 1 wherein: A is a single bond R 4 is a norbornyl or adamantyl group R 5 is a methyl group R 1 is a sulfamoyl group or a, C 1-2 alkylsulfonyl group R 2 is a hydrogen atom, an amino group or is joined with R 1 to form an azimido group R 3 is a hydrogen atom.
Claim 4
Dependent Claim 5 words
N-(1-adamantyl 2-pyrrolidinylmethyl) 2-methoxy 5-methylsulfonyl benzamide.
Claim 5
Dependent Claim 5 words
N-(1-adamantyl 2-pyrrolidinylmethyl) 2-methoxy 5-methylsulfonyl benzamide.
Claim 6
Dependent Claim 5 words
N-(1-adamantyl 2-pyrrolidinylmethyl) 2-methoxy 5-ethylsulfonyl benzamide.
Claim 7
Dependent Claim 5 words
N-(1-adamantyl 2-pyrrolidinylmethyl) 2-methoxy 5-ethylsulfonyl benzamide.
Claim 8
Dependent Claim 22 words
A pharmaceutical composition having anti-emetic activity which comprises the substituted heterocyclic benzamide of claim 1 or 2 and a pharmaceutically acceptable carrier.
Claim 9
Dependent Claim 30 words
A process for the treatment of nausea in patients which comprises administering an effective amount of the substituted heterocyclic benzamide of claim 1 or 2 and a pharmaceutically acceptable carrier.
Claim 10
Dependent Claim 4 words
N-(1-(2'-norbornyl)-2-pyrrolidinyl methyl) 2-methoxy-4-amino-5-ethylsulfonyl benzamide.
Claim 11
Dependent Claim 4 words
N-(1-(2'-norbornyl)-2-pyrrolidinyl methyl) 2-methoxy-4-amino-5-ethylsulfonyl benzamide.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1990-06-15 1990-12-15 1991-06-16 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1994-06-15 1994-12-15 1995-06-16 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1998-06-15 1998-12-15 1999-06-16 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag